MDLs to Watch: Onglyza and Kombligyze XR

In February, the United States Judicial Panel on Multidistrict Litigation issued an order centralizing pre-trial proceedings in actions against the manufacturers of Onglyza and Kombligyze XR, medications used to treat Type 2 Diabetes Mellitus. When the centralization was ordered, the…